A hallmark of human immunodeficiency virus-1 (HIV) infection is the resultant depletion of CD4 T lymphocytes; however, with the advent of antiretroviral therapy (ART), a gradual recovery in CD4 T-cell counts occurs to an immune-competent range (>500 cells/μl) if viral suppression is retained. The gene discussed is CD4; the disease is HIV infectious disease.